Guidance for Exact Sciences (EXAS)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2025 | N/A | N/A | $3.22B – 3.24B | $3.16B | = Maintained | Details |
| 2025 | N/A | N/A | $3.13B – 3.17B | $3.10B | Raised |
Details |
| 2025 | N/A | N/A | $3.07B – 3.12B | $3.90B | = Maintained | Details |
| 2025 | N/A | N/A | $3.03B – 3.09B | $3.06B | = Maintained | Details |
| 2024 | N/A | N/A | $2.73B – 2.75B | $2.83B | Lowered |
Details |
| 2024 | N/A | N/A | $2.81B – 2.85B | $2.83B | = Maintained | Details |
| 2024 | N/A | N/A | $2.81B – 2.85B | $2.83B | = Maintained | Details |
| 2024 | N/A | N/A | $2.81B – 2.85B | $2.83B | = Maintained | Details |
| 2023 | N/A | N/A | $2.44M – 2.47M | $2.42M | = Maintained | Details |
| 2023 | N/A | N/A | $2.38B – 2.42B | $2.30B | = Maintained | Details |
| 2023 | N/A | N/A | $2265.00M – 2315.00M | $2289.00M | = Maintained | Details |
| 2022 | N/A | N/A | $2.03B – 2.04B | $2.01B | = Maintained | Details |
| 2022 | N/A | N/A | $1.99B – 2.03B | $2.01B | = Maintained | Details |
| 2022 | N/A | N/A | $1.98B – 2.03B | $1.99B | = Maintained | Details |
| Q3 2022 | N/A | N/A | $1.98B – 2.02B | $2.02B | = Maintained | Details |
| 2021 | N/A | N/A | $1.72B – 1.74B | $1.73B | = Maintained | Details |
| 2021 | N/A | N/A | $1.71B – 1.75B | $1.72B | = Maintained | Details |
| Q2 2021 | N/A | N/A | $1.69B – 1.74B | $1.72B | = Maintained | Details |
| 2020 | N/A | N/A | $1.61M – 1.65M | $1.59M | = Maintained | Details |
| 2019 | N/A | N/A | $802.00M – 810.00M | $810.87M | = Maintained | Details |
| 2019 | N/A | N/A | $725.00M – 740.00M | $729.50M | Raised |
Details |
| 2019 | N/A | N/A | $710.00M – 730.00M | $704.35M | Raised |
Details |
| 2018 | N/A | N/A | $435.00M – 440.00M | $428.75M | = Maintained | Details |
| 2018 | N/A | N/A | $420.00M – 430.00M | $435.80M | = Maintained | Details |
| 2018 | N/A | N/A | $420.00M – 430.00M | $431.70M | = Maintained | Details |
| 2018 | N/A | N/A | $420.00M – 430.00M | $422.13M | = Maintained | Details |
| 2017 | N/A | N/A | $254.00M – 257.00M | $244.25M | Raised |
Details |
| 2017 | N/A | N/A | $195.00M – 205.00M | $178.00M | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | N/A | N/A | $93.00M – 95.00M | $90.90M | Raised |
Details |


Raised
Lowered